Ads
related to: renal cell carcinoma treatment- How This Treatment Works
Learn More About How This
FDA-Approved Treatment Works.
- FAQs
Find FAQs For This Treatment
Option On The Official Patient Site
- Clinical Trial Info
Review Clinical Trial Results For
This FDA-Approved Treatment Option.
- Dosing Information
Get Dosing And Treatment
Schedule Information.
- How This Treatment Works
Search results
Eisai Showcases Oncology Portfolio and Pipeline at ASCO 2024
FOX 23 News Albany· 3 hours agoNotable data include an oral presentation on biomarker analyses from the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581 trial (NCT02811861), which evaluated lenvatinib (LENVIMA®), the orally ...
Tumor mutations may not predict response to immunotherapy, study finds
Medical Xpress· 39 minutes agoThe findings, published in Nature Cancer, upend long-held conventional wisdom and could lead to more effective ways of deciding which patients will benefit most from this type of treatment ...
Kidney Cancer Immunotherapy Response Linked to Signature Reflecting HLA, Tumor Immune Activity
GenomeWeb News· 2 days agoResearchers found an immune checkpoint blockade response signature in renal cell carcinoma that reflects tumor immune activity influenced by human leukocyte antigen features.
Get Ready for ASCO 2024 Annual Meeting | Newswise
Newswise· 1 day agoASCO, the largest event in cancer research, is approaching on May 31st. This year's meeting promises to be particularly groundbreaking, with new findings a
Ipilimumab, a Pioneer Breakthrough in Cancer Treatment
Forbes· 3 days agoIn 2011, the first in a new generation of anticancer drugs called checkpoint inhibitors was...
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Zacks via Yahoo Finance· 23 hours agoDr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop...
Great Lakes Advisors LLC Has $1.11 Million Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 1 day agoGreat Lakes Advisors LLC trimmed its holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 50.8% during the fourth quarter, according to its most recent 13F filing with the ...
Maintenance Tx With Guselkumab for UC Meets All Endpoints
Medscape· 1 day agoGuselkumab (Tremfya, Janssen/Johnson & Johnson) was superior to placebo for maintenance therapy in...
Exelixis, Inc. (NASDAQ:EXEL) Shares Bought by BNP Paribas Financial Markets
ETF DAILY NEWS· 6 days agoBNP Paribas Financial Markets increased its stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 88.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities ...
Swiss National Bank Has $3.57 Million Stock Holdings in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 2 days agoSwiss National Bank lowered its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 10.2% in the fourth quarter, according to its most recent 13F filing with the ...
Ads
related to: renal cell carcinoma treatment